Grant Stuart 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 18, 2011
Insider Transaction Report
Form 4
Grant Stuart
SR VP & CFO
Transactions
- Exercise/Conversion
Emp. Stock Option (Right to Buy)
2011-03-16−31,385→ 55,751 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (31,385 underlying) - Sale
Common Stock
2011-03-16$3.39/sh−16,615$56,325→ 14,717 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2011-03-16−17,000→ 38,751 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (17,000 underlying) - Exercise/Conversion
Common Stock
2011-03-16$1.20/sh+16,615$19,938→ 31,332 total - Sale
Common Stock
2011-03-16$3.40/sh−6,000$20,400→ 57,102 total - Exercise/Conversion
Common Stock
2011-03-16$1.20/sh+17,000$20,400→ 63,102 total - Exercise/Conversion
Emp. Stock Option (Right to Buy)
2011-03-16−16,615→ 87,136 totalExercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (16,615 underlying) - Exercise/Conversion
Common Stock
2011-03-16$1.20/sh+31,385$37,662→ 46,102 total
Footnotes (1)
- [F1]These shares were transferred to the Company by the reporting person in partial payment of the exercise price of the stock options exercised on March 16, 2011.